Denrit – Gefetinib 250mg Tablet
Description
GEFITINIB (DENRIT) TABLET – TREATMENT FOR LUNG CANCER
Gefitinib or Denrit 250mg Tablet is a non-small cell lung cancer medication. It is used in patients whose cancer has progressed to other parts of their bodies, who have faulty epidermal growth factor receptor (EGFR) genes, and who have not previously received cancer treatment.
Non-small cell lung cancer is one of the most common types of lung cancer, affecting both smokers and nonsmokers. Denrit 250mg Tablet is used to treat non-small cell lung cancer and can be taken alone or in conjunction with other medications. It is a potent and highly poisonous medication, and you should consult your doctor about the dangers and advantages.
Fedelty Health Care is a Gefitinib wholesaler, Pharmaceutical Cargo Bulk Exporter & Hospital Supply.
USES OF GEFITINIB (DENRIT) TABLET
- Non-small cell lung cancer
WORKS OF GEFITINIB (DENRIT) TABLET
Denrit 250mg Tablet is a cancer-fighting medicine. It works by preventing the aberrant protein from signaling cancer cells to proliferate. This aids in the prevention or slowing of the spread of cancer cells.
Fedelty Health Care is a Gefitinib wholesaler, Pharmaceutical Cargo Bulk Exporter & Hospital Supply.
SIDE EFFECTS OF GEFITINIB (DENRIT) TABLET
The majority of adverse effects do not necessitate medical treatment and will go away as your body adjusts to the medication. Consult your doctor if they persist or if you are concerned.
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Vomiting
- Weakness
- Weight loss
WARNING & PRECAUTIONS
- Driving
Denrit 250mg Side effects from the tablet may impair your ability to drive.
Denrit 250mg Tablet may make you feel weak. This may impair your driving skills.
- Kidney
In patients with severe kidney disease, Denrit 250mg Tablet should be taken with caution. Denrit 250mg Tablet dosage may need to be adjusted. Please consult your physician.
- Liver
Denrit 250mg Tablet is most likely safe for patients with liver problems to take. Based on the current data, it appears that no dose change of Denrit 250mg Tablet is required in these patients. Please consult your physician.
- Pregnancy
Denrit 250mg Tablet should not be used during pregnancy because there is clear evidence of danger to the developing fetus. However, if the advantages outweigh the hazards, the doctor may seldom prescribe it in life-threatening conditions. Please consult your physician.
Fedelty Health Care is a  Gefitinib third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.
